Global Artemisinin Combination Therapy Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
158
Industry
Therapeutic Area
Regions
Global
Updated
April 2026

Report Overview


Report Overview
Artemisinin Combination Therapy is recommended for thetreatment of P. falciparum malaria. Fast acting artemisinin-based compounds arecombined with a drug from a different class and artemisinin derivatives include dihydroartemisinin, artesunate and artemether.

The global Artemisinin Combination Therapy market size was estimated at USD 393.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.80% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Artemisinin Combination Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Artemisinin Combination Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Artemisinin Combination Therapy market.
Global Artemisinin Combination Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
KPC Pharmaceuticals
Shanghai Fosun Pharmaceutical Industrial Development
Sanofi
Desano Holdings
Calyx Chemicals and Pharmaceuticals
Mylan
Novartis
Denk Pharma
Hovid Berhad
Ipca Laboratories
Cipla
Aspen Pharmacare Holdings
Ajanta Pharma
Guilin Pharmaceuticals

Market Segmentation (by Type)
Artemether+Lumefantrine
Artesunate+Amodiaquine
Dihydroartemisinin+Piperaquine
Artesunate+Mefloquine
Artesunate+Sulfadoxine-Pyrimethamine
Pyronaridine-Artesunate
Other

Market Segmentation (by Application)
Hospital
Clinic
Other

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Artemisinin Combination Therapy Market
Overview of the regional outlook of the Artemisinin Combination Therapy Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Artemisinin Combination Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Artemisinin Combination Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Artemisinin Combination Therapy
    • 1.2 Key Market Segments
      • 1.2.1 Artemisinin Combination Therapy Segment by Type
      • 1.2.2 Artemisinin Combination Therapy Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 Artemisinin Combination Therapy Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Artemisinin Combination Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global Artemisinin Combination Therapy Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Artemisinin Combination Therapy Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global Artemisinin Combination Therapy Product Life Cycle
    • 3.3 Global Artemisinin Combination Therapy Sales by Manufacturers (2020-2025)
    • 3.4 Global Artemisinin Combination Therapy Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 Artemisinin Combination Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global Artemisinin Combination Therapy Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
    • 3.8 Artemisinin Combination Therapy Market Competitive Situation and Trends
      • 3.8.1 Artemisinin Combination Therapy Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest Artemisinin Combination Therapy Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 Artemisinin Combination Therapy Industry Chain Analysis
    • 4.1 Artemisinin Combination Therapy Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Artemisinin Combination Therapy Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global Artemisinin Combination Therapy Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy – April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to Artemisinin Combination Therapy Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 Artemisinin Combination Therapy Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Artemisinin Combination Therapy Sales Market Share by Type (2020-2025)
    • 6.3 Global Artemisinin Combination Therapy Market Size by Type (2020-2025)
    • 6.4 Global Artemisinin Combination Therapy Price by Type (2020-2025)
  • 7 Artemisinin Combination Therapy Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Artemisinin Combination Therapy Market Sales by Application (2020-2025)
    • 7.3 Global Artemisinin Combination Therapy Market Size (M USD) by Application (2020-2025)
    • 7.4 Global Artemisinin Combination Therapy Sales Growth Rate by Application (2020-2025)
  • 8 Artemisinin Combination Therapy Market Sales by Region
    • 8.1 Global Artemisinin Combination Therapy Sales by Region
      • 8.1.1 Global Artemisinin Combination Therapy Sales by Region
      • 8.1.2 Global Artemisinin Combination Therapy Sales Market Share by Region
    • 8.2 Global Artemisinin Combination Therapy Market Size by Region
      • 8.2.1 Global Artemisinin Combination Therapy Market Size by Region
      • 8.2.2 Global Artemisinin Combination Therapy Market Size by Region
    • 8.3 North America
      • 8.3.1 North America Artemisinin Combination Therapy Sales by Country
      • 8.3.2 North America Artemisinin Combination Therapy Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe Artemisinin Combination Therapy Sales by Country
      • 8.4.2 Europe Artemisinin Combination Therapy Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific Artemisinin Combination Therapy Sales by Region
      • 8.5.2 Asia Pacific Artemisinin Combination Therapy Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America Artemisinin Combination Therapy Sales by Country
      • 8.6.2 South America Artemisinin Combination Therapy Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa Artemisinin Combination Therapy Sales by Region
      • 8.7.2 Middle East and Africa Artemisinin Combination Therapy Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 Artemisinin Combination Therapy Market Production by Region
    • 9.1 Global Production of Artemisinin Combination Therapy by Region(2020-2025)
    • 9.2 Global Artemisinin Combination Therapy Revenue Market Share by Region (2020-2025)
    • 9.3 Global Artemisinin Combination Therapy Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America Artemisinin Combination Therapy Production
      • 9.4.1 North America Artemisinin Combination Therapy Production Growth Rate (2020-2025)
      • 9.4.2 North America Artemisinin Combination Therapy Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe Artemisinin Combination Therapy Production
      • 9.5.1 Europe Artemisinin Combination Therapy Production Growth Rate (2020-2025)
      • 9.5.2 Europe Artemisinin Combination Therapy Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan Artemisinin Combination Therapy Production (2020-2025)
      • 9.6.1 Japan Artemisinin Combination Therapy Production Growth Rate (2020-2025)
      • 9.6.2 Japan Artemisinin Combination Therapy Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China Artemisinin Combination Therapy Production (2020-2025)
      • 9.7.1 China Artemisinin Combination Therapy Production Growth Rate (2020-2025)
      • 9.7.2 China Artemisinin Combination Therapy Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 KPC Pharmaceuticals
      • 10.1.1 KPC Pharmaceuticals Basic Information
      • 10.1.2 KPC Pharmaceuticals Artemisinin Combination Therapy Product Overview
      • 10.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Product Market Performance
      • 10.1.4 KPC Pharmaceuticals Business Overview
      • 10.1.5 KPC Pharmaceuticals SWOT Analysis
      • 10.1.6 KPC Pharmaceuticals Recent Developments
    • 10.2 Shanghai Fosun Pharmaceutical Industrial Development
      • 10.2.1 Shanghai Fosun Pharmaceutical Industrial Development Basic Information
      • 10.2.2 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product Overview
      • 10.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product Market Performance
      • 10.2.4 Shanghai Fosun Pharmaceutical Industrial Development Business Overview
      • 10.2.5 Shanghai Fosun Pharmaceutical Industrial Development SWOT Analysis
      • 10.2.6 Shanghai Fosun Pharmaceutical Industrial Development Recent Developments
    • 10.3 Sanofi
      • 10.3.1 Sanofi Basic Information
      • 10.3.2 Sanofi Artemisinin Combination Therapy Product Overview
      • 10.3.3 Sanofi Artemisinin Combination Therapy Product Market Performance
      • 10.3.4 Sanofi Business Overview
      • 10.3.5 Sanofi SWOT Analysis
      • 10.3.6 Sanofi Recent Developments
    • 10.4 Desano Holdings
      • 10.4.1 Desano Holdings Basic Information
      • 10.4.2 Desano Holdings Artemisinin Combination Therapy Product Overview
      • 10.4.3 Desano Holdings Artemisinin Combination Therapy Product Market Performance
      • 10.4.4 Desano Holdings Business Overview
      • 10.4.5 Desano Holdings Recent Developments
    • 10.5 Calyx Chemicals and Pharmaceuticals
      • 10.5.1 Calyx Chemicals and Pharmaceuticals Basic Information
      • 10.5.2 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product Overview
      • 10.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product Market Performance
      • 10.5.4 Calyx Chemicals and Pharmaceuticals Business Overview
      • 10.5.5 Calyx Chemicals and Pharmaceuticals Recent Developments
    • 10.6 Mylan
      • 10.6.1 Mylan Basic Information
      • 10.6.2 Mylan Artemisinin Combination Therapy Product Overview
      • 10.6.3 Mylan Artemisinin Combination Therapy Product Market Performance
      • 10.6.4 Mylan Business Overview
      • 10.6.5 Mylan Recent Developments
    • 10.7 Novartis
      • 10.7.1 Novartis Basic Information
      • 10.7.2 Novartis Artemisinin Combination Therapy Product Overview
      • 10.7.3 Novartis Artemisinin Combination Therapy Product Market Performance
      • 10.7.4 Novartis Business Overview
      • 10.7.5 Novartis Recent Developments
    • 10.8 Denk Pharma
      • 10.8.1 Denk Pharma Basic Information
      • 10.8.2 Denk Pharma Artemisinin Combination Therapy Product Overview
      • 10.8.3 Denk Pharma Artemisinin Combination Therapy Product Market Performance
      • 10.8.4 Denk Pharma Business Overview
      • 10.8.5 Denk Pharma Recent Developments
    • 10.9 Hovid Berhad
      • 10.9.1 Hovid Berhad Basic Information
      • 10.9.2 Hovid Berhad Artemisinin Combination Therapy Product Overview
      • 10.9.3 Hovid Berhad Artemisinin Combination Therapy Product Market Performance
      • 10.9.4 Hovid Berhad Business Overview
      • 10.9.5 Hovid Berhad Recent Developments
    • 10.10 Ipca Laboratories
      • 10.10.1 Ipca Laboratories Basic Information
      • 10.10.2 Ipca Laboratories Artemisinin Combination Therapy Product Overview
      • 10.10.3 Ipca Laboratories Artemisinin Combination Therapy Product Market Performance
      • 10.10.4 Ipca Laboratories Business Overview
      • 10.10.5 Ipca Laboratories Recent Developments
    • 10.11 Cipla
      • 10.11.1 Cipla Basic Information
      • 10.11.2 Cipla Artemisinin Combination Therapy Product Overview
      • 10.11.3 Cipla Artemisinin Combination Therapy Product Market Performance
      • 10.11.4 Cipla Business Overview
      • 10.11.5 Cipla Recent Developments
    • 10.12 Aspen Pharmacare Holdings
      • 10.12.1 Aspen Pharmacare Holdings Basic Information
      • 10.12.2 Aspen Pharmacare Holdings Artemisinin Combination Therapy Product Overview
      • 10.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Product Market Performance
      • 10.12.4 Aspen Pharmacare Holdings Business Overview
      • 10.12.5 Aspen Pharmacare Holdings Recent Developments
    • 10.13 Ajanta Pharma
      • 10.13.1 Ajanta Pharma Basic Information
      • 10.13.2 Ajanta Pharma Artemisinin Combination Therapy Product Overview
      • 10.13.3 Ajanta Pharma Artemisinin Combination Therapy Product Market Performance
      • 10.13.4 Ajanta Pharma Business Overview
      • 10.13.5 Ajanta Pharma Recent Developments
    • 10.14 Guilin Pharmaceuticals
      • 10.14.1 Guilin Pharmaceuticals Basic Information
      • 10.14.2 Guilin Pharmaceuticals Artemisinin Combination Therapy Product Overview
      • 10.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Product Market Performance
      • 10.14.4 Guilin Pharmaceuticals Business Overview
      • 10.14.5 Guilin Pharmaceuticals Recent Developments
  • 11 Artemisinin Combination Therapy Market Forecast by Region
    • 11.1 Global Artemisinin Combination Therapy Market Size Forecast
    • 11.2 Global Artemisinin Combination Therapy Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe Artemisinin Combination Therapy Market Size Forecast by Country
      • 11.2.3 Asia Pacific Artemisinin Combination Therapy Market Size Forecast by Region
      • 11.2.4 South America Artemisinin Combination Therapy Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of Artemisinin Combination Therapy by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global Artemisinin Combination Therapy Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of Artemisinin Combination Therapy by Type (2026-2035)
      • 12.1.2 Global Artemisinin Combination Therapy Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of Artemisinin Combination Therapy by Type (2026-2035)
    • 12.2 Global Artemisinin Combination Therapy Market Forecast by Application (2026-2035)
      • 12.2.1 Global Artemisinin Combination Therapy Sales (K Units) Forecast by Application
      • 12.2.2 Global Artemisinin Combination Therapy Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.